https://cohostpodcasting.com <![CDATA[The Persistence Lab]]> en d8aefdaa-a17b-4dbb-bea2-50ca5372d89b Tue, 20 Jan 2026 14:16:38 -0500 Thu, 16 Jul 2026 14:05:49 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html <![CDATA[The Persistence Lab]]> https://files.cohostpodcasting.com/quill-file-prod/e6f8ee87-47be-4a8e-a2cd-6c7f13dff165/shows/d8aefdaa-a17b-4dbb-bea2-50ca5372d89b/cover-art/original_47351c817c9c243b340d6c12423f4666.png https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html episodic false https://feeds.cohostpodcasting.com/hKtZTXcW podcasts@jaraudio.com <![CDATA[Inside the Mind of a Scientist]]> We often experience science through the breakthrough announced in the news. But that moment comes at the end of a long and arduous process that often began years earlier. Understanding this journey, and the people who dedicate their careers to these efforts, can bring us one step closer to appreciating the value of that breakthrough. In the season finale of The Persistence Lab, a podcast from AbbVie, we revisit our conversations with the scientists and experts from this season to understand how optimism becomes a strategy to drive innovation, not just a mindset. Not intended for UK audiences.


For more information on AbbVie’s culture of scientific innovation, visit: https://www.abbvie.com/science/our-people.html.

]]> Thu, 25 Jun 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 15:56 We often experience science through the breakthrough announced in the news. But that moment comes at the end of a long and arduous process that often began years earlier. Understanding this journey, and the people who dedicate their careers to these efforts, can bring us one step closer to appreciating the value of that breakthrough. In the season finale of The Persistence Lab, a podcast from AbbVie, we revisit our conversations with the scientists and experts from this season to understand how optimism becomes a strategy to drive innovation, not just a mindset. Not intended for UK audiences.


For more information on AbbVie’s culture of scientific innovation, visit: https://www.abbvie.com/science/our-people.html.

]]> We often experience science through the breakthrough announced in the news. But that moment comes at the end of a long and arduous process that often began years earlier. Understanding this journey, and the people who dedicate their careers to these efforts, can bring us one step closer to appreciating the value of that breakthrough. In the season finale of The Persistence Lab, a podcast from AbbVie, we revisit our conversations with the scientists and experts from this season to understand how optimism becomes a strategy to drive innovation, not just a mindset. Not intended for UK audiences.


For more information on AbbVie’s culture of scientific innovation, visit: https://www.abbvie.com/science/our-people.html.

]]> false full 10 1 <![CDATA[Can Scientists Slow Down Brain Disorders?]]> Neurodegenerative diseases, like Alzheimer’s disease and Parkinson’s disease, are conditions that lead to a gradual, cumulative loss of neural activity in the brain. There are currently no cures for these conditions, and current care regimens focus on managing the symptoms of these diseases. In this episode, sponsored by AbbVie, we look at the impact of neurological conditions on patients and their families, and the persistence of the scientists and researchers who are exploring new clinical approaches that could potentially change the way these neurological conditions are treated. Not intended for UK audiences. 


For more information on AbbVie’s efforts in neuroscience, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html.

]]> Thu, 11 Jun 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 20:34 Neurodegenerative diseases, like Alzheimer’s disease and Parkinson’s disease, are conditions that lead to a gradual, cumulative loss of neural activity in the brain. There are currently no cures for these conditions, and current care regimens focus on managing the symptoms of these diseases. In this episode, sponsored by AbbVie, we look at the impact of neurological conditions on patients and their families, and the persistence of the scientists and researchers who are exploring new clinical approaches that could potentially change the way these neurological conditions are treated. Not intended for UK audiences. 


For more information on AbbVie’s efforts in neuroscience, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html.

]]> Neurodegenerative diseases, like Alzheimer’s disease and Parkinson’s disease, are conditions that lead to a gradual, cumulative loss of neural activity in the brain. There are currently no cures for these conditions, and current care regimens focus on managing the symptoms of these diseases. In this episode, sponsored by AbbVie, we look at the impact of neurological conditions on patients and their families, and the persistence of the scientists and researchers who are exploring new clinical approaches that could potentially change the way these neurological conditions are treated. Not intended for UK audiences. 


For more information on AbbVie’s efforts in neuroscience, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html.

]]> false full 9 1 <![CDATA[Not Lost in Translation]]> Why do some patients with autoimmune disease respond to treatment while others may not? Understanding these insights can offer scientists potential clues about the underlying cause of disease. This episode, sponsored by AbbVie, explores the approaches scientists use to help drive progress in immunology research like reverse translation – a process that works from “bedside to bench” using clinical observation and patient data to inform and refine drug development earlier on in the process. Not intended for UK audiences.


To learn more about AbbVie’s efforts in immunology, visit: https://www.abbvie.com/science/areas-of-focus/immunology.html

]]> Thu, 28 May 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 20:18 Why do some patients with autoimmune disease respond to treatment while others may not? Understanding these insights can offer scientists potential clues about the underlying cause of disease. This episode, sponsored by AbbVie, explores the approaches scientists use to help drive progress in immunology research like reverse translation – a process that works from “bedside to bench” using clinical observation and patient data to inform and refine drug development earlier on in the process. Not intended for UK audiences.


To learn more about AbbVie’s efforts in immunology, visit: https://www.abbvie.com/science/areas-of-focus/immunology.html

]]> Why do some patients with autoimmune disease respond to treatment while others may not? Understanding these insights can offer scientists potential clues about the underlying cause of disease. This episode, sponsored by AbbVie, explores the approaches scientists use to help drive progress in immunology research like reverse translation – a process that works from “bedside to bench” using clinical observation and patient data to inform and refine drug development earlier on in the process. Not intended for UK audiences.


To learn more about AbbVie’s efforts in immunology, visit: https://www.abbvie.com/science/areas-of-focus/immunology.html

]]> false full 8 1 <![CDATA[The Answer Is Inside You: The Complexities of Autoimmune Research]]> The immune system is our greatest defense – a shield that protects us from harmful diseases. But what happens when it misfires and attacks the body with no pathogens in sight? For decades, scientists have been working to find ways to address the conditions that result from this process, like rheumatoid arthritis or lupus. This episode, sponsored by AbbVie, traces how scientists’ understanding of immune activation has evolved and explores new clinical approaches that aim to reset the immune system. It’s a story of turning inward to finding the answers already written in our biology. Not intended for UK audiences.


For more information about the technologies and platforms informing AbbVie’s therapeutic approaches, visit: https://abbv.ie/092d64

]]> Thu, 14 May 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 19:35 The immune system is our greatest defense – a shield that protects us from harmful diseases. But what happens when it misfires and attacks the body with no pathogens in sight? For decades, scientists have been working to find ways to address the conditions that result from this process, like rheumatoid arthritis or lupus. This episode, sponsored by AbbVie, traces how scientists’ understanding of immune activation has evolved and explores new clinical approaches that aim to reset the immune system. It’s a story of turning inward to finding the answers already written in our biology. Not intended for UK audiences.


For more information about the technologies and platforms informing AbbVie’s therapeutic approaches, visit: https://abbv.ie/092d64

]]> The immune system is our greatest defense – a shield that protects us from harmful diseases. But what happens when it misfires and attacks the body with no pathogens in sight? For decades, scientists have been working to find ways to address the conditions that result from this process, like rheumatoid arthritis or lupus. This episode, sponsored by AbbVie, traces how scientists’ understanding of immune activation has evolved and explores new clinical approaches that aim to reset the immune system. It’s a story of turning inward to finding the answers already written in our biology. Not intended for UK audiences.


For more information about the technologies and platforms informing AbbVie’s therapeutic approaches, visit: https://abbv.ie/092d64

]]> false full 7 1 <![CDATA[Beyond the Skin's Surface]]> What does it really mean to feel good in your own skin? Despite the number of patients who achieve natural-looking results from dermal fillers, social media and online sources have disproportionately amplified stories of the outliers. Providers now play an important role in educating audiences about these medicines – knowledge that can help lead to more informed conversations. In this episode, sponsored by AbbVie, we dive deep into the world of aesthetic medicine, focusing on how education about the science of these treatments can build trust and break down barriers to care. Not intended for UK audiences.


For more information about AbbVie’s research in aesthetic medicine, visit: https://www.abbvie.com/science/areas-of-focus/aesthetics.html.

]]> Thu, 30 Apr 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 19:09 What does it really mean to feel good in your own skin? Despite the number of patients who achieve natural-looking results from dermal fillers, social media and online sources have disproportionately amplified stories of the outliers. Providers now play an important role in educating audiences about these medicines – knowledge that can help lead to more informed conversations. In this episode, sponsored by AbbVie, we dive deep into the world of aesthetic medicine, focusing on how education about the science of these treatments can build trust and break down barriers to care. Not intended for UK audiences.


For more information about AbbVie’s research in aesthetic medicine, visit: https://www.abbvie.com/science/areas-of-focus/aesthetics.html.

]]> What does it really mean to feel good in your own skin? Despite the number of patients who achieve natural-looking results from dermal fillers, social media and online sources have disproportionately amplified stories of the outliers. Providers now play an important role in educating audiences about these medicines – knowledge that can help lead to more informed conversations. In this episode, sponsored by AbbVie, we dive deep into the world of aesthetic medicine, focusing on how education about the science of these treatments can build trust and break down barriers to care. Not intended for UK audiences.


For more information about AbbVie’s research in aesthetic medicine, visit: https://www.abbvie.com/science/areas-of-focus/aesthetics.html.

]]> false full 6 1 <![CDATA[Cancer's Clues: How Biomarkers are Changing the Game for Scientists]]> For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences.


To learn more about AbbVie’s research in oncology, visit: https://www.abbvie.com/science/areas-of-focus/oncology.html.

]]> Thu, 16 Apr 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 19:31 For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences.


To learn more about AbbVie’s research in oncology, visit: https://www.abbvie.com/science/areas-of-focus/oncology.html.

]]> For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences.


To learn more about AbbVie’s research in oncology, visit: https://www.abbvie.com/science/areas-of-focus/oncology.html.

]]> false full 5 1 <![CDATA[Smart Packaging]]> Medication access goes beyond the ability to obtain the medication prescribed – it's also about the logistics: developing, manufacturing and delivering a medicine. This episode, sponsored by AbbVie, explores how teams are rethinking operations and manufacturing to prioritize the most important piece of the puzzle: the patient. Behind every package that reaches a patient lies remarkable science, dedication, and ingenuity, ensuring that care makes it all the way to those who need it most. Not intended for UK audiences.


To find out more about AbbVie’s operations and manufacturing capabilities, visit: https://www.abbvie.com/who-we-are/our-stories/how-abbvies-integrated-operations-help-prevent-drug-shortages.html

]]> Thu, 02 Apr 2026 04:01:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 19:36 Medication access goes beyond the ability to obtain the medication prescribed – it's also about the logistics: developing, manufacturing and delivering a medicine. This episode, sponsored by AbbVie, explores how teams are rethinking operations and manufacturing to prioritize the most important piece of the puzzle: the patient. Behind every package that reaches a patient lies remarkable science, dedication, and ingenuity, ensuring that care makes it all the way to those who need it most. Not intended for UK audiences.


To find out more about AbbVie’s operations and manufacturing capabilities, visit: https://www.abbvie.com/who-we-are/our-stories/how-abbvies-integrated-operations-help-prevent-drug-shortages.html

]]> Medication access goes beyond the ability to obtain the medication prescribed – it's also about the logistics: developing, manufacturing and delivering a medicine. This episode, sponsored by AbbVie, explores how teams are rethinking operations and manufacturing to prioritize the most important piece of the puzzle: the patient. Behind every package that reaches a patient lies remarkable science, dedication, and ingenuity, ensuring that care makes it all the way to those who need it most. Not intended for UK audiences.


To find out more about AbbVie’s operations and manufacturing capabilities, visit: https://www.abbvie.com/who-we-are/our-stories/how-abbvies-integrated-operations-help-prevent-drug-shortages.html

]]> false full 4 1 <![CDATA[Help on the Line]]> For many patients, navigating the health care system can be painstakingly difficult. But a conversation with an advocate can change everything. In this episode, sponsored by AbbVie, we follow the patient journey through the complexities of the health care system. Along the way, we meet people behind AbbVie’s patient support teams, who aim to help patients feel seen, heard, and empowered. Not intended for UK audiences.


To find out more about AbbVie patient support, visit: www.abbvie.com/patients/patient-support.html

]]> Thu, 19 Mar 2026 05:00:00 -0400 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 24:53 For many patients, navigating the health care system can be painstakingly difficult. But a conversation with an advocate can change everything. In this episode, sponsored by AbbVie, we follow the patient journey through the complexities of the health care system. Along the way, we meet people behind AbbVie’s patient support teams, who aim to help patients feel seen, heard, and empowered. Not intended for UK audiences.


To find out more about AbbVie patient support, visit: www.abbvie.com/patients/patient-support.html

]]> For many patients, navigating the health care system can be painstakingly difficult. But a conversation with an advocate can change everything. In this episode, sponsored by AbbVie, we follow the patient journey through the complexities of the health care system. Along the way, we meet people behind AbbVie’s patient support teams, who aim to help patients feel seen, heard, and empowered. Not intended for UK audiences.


To find out more about AbbVie patient support, visit: www.abbvie.com/patients/patient-support.html

]]> false full 3 1 <![CDATA[Entering the Fortress: Navigating the Blood-Brain Barrier]]> Is it possible to deliver medicine to the brain when the brain won’t let it in? The blood-brain barrier is the brain’s personal fortress, protecting it from potentially dangerous pathogens. But that same barrier can also prevent the delivery of medicines. In this episode, sponsored by AbbVie, we meet the scientists exploring the use of shuttle technology to navigate the blood-brain barrier and potentially address conditions of the brain. It’s a story of scientific persistence and the new approaches that might develop when you stop trying to knock down the door and learn how to unlock it. Not intended for UK audiences.


To learn about AbbVie’s approach to neuroscience research, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html

]]> Thu, 05 Mar 2026 05:00:00 -0500 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 18:08 Is it possible to deliver medicine to the brain when the brain won’t let it in? The blood-brain barrier is the brain’s personal fortress, protecting it from potentially dangerous pathogens. But that same barrier can also prevent the delivery of medicines. In this episode, sponsored by AbbVie, we meet the scientists exploring the use of shuttle technology to navigate the blood-brain barrier and potentially address conditions of the brain. It’s a story of scientific persistence and the new approaches that might develop when you stop trying to knock down the door and learn how to unlock it. Not intended for UK audiences.


To learn about AbbVie’s approach to neuroscience research, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html

]]> Is it possible to deliver medicine to the brain when the brain won’t let it in? The blood-brain barrier is the brain’s personal fortress, protecting it from potentially dangerous pathogens. But that same barrier can also prevent the delivery of medicines. In this episode, sponsored by AbbVie, we meet the scientists exploring the use of shuttle technology to navigate the blood-brain barrier and potentially address conditions of the brain. It’s a story of scientific persistence and the new approaches that might develop when you stop trying to knock down the door and learn how to unlock it. Not intended for UK audiences.


To learn about AbbVie’s approach to neuroscience research, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html

]]> false full 2 1 <![CDATA[Can We Find Cures Faster?]]> Our health and well-being impact every element of our lives. For patients with some of the most difficult-to-treat medical conditions, a cure is what they’re hoping for. How can we accelerate drug development to spur progress and turn bold ideas into real breakthroughs? We launch our journey into The Persistence Lab, a podcast sponsored by AbbVie, with a look at how the company is empowering scientists to boldly rethink what it means to cure disease and accelerate care for patients. Not intended for UK audiences.


To learn more about AbbVie’s approach to scientific discovery, visit: https://www.abbvie.com/science/our-people/community-of-science.html

]]> Thu, 19 Feb 2026 05:00:00 -0500 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 22:35 Our health and well-being impact every element of our lives. For patients with some of the most difficult-to-treat medical conditions, a cure is what they’re hoping for. How can we accelerate drug development to spur progress and turn bold ideas into real breakthroughs? We launch our journey into The Persistence Lab, a podcast sponsored by AbbVie, with a look at how the company is empowering scientists to boldly rethink what it means to cure disease and accelerate care for patients. Not intended for UK audiences.


To learn more about AbbVie’s approach to scientific discovery, visit: https://www.abbvie.com/science/our-people/community-of-science.html

]]> Our health and well-being impact every element of our lives. For patients with some of the most difficult-to-treat medical conditions, a cure is what they’re hoping for. How can we accelerate drug development to spur progress and turn bold ideas into real breakthroughs? We launch our journey into The Persistence Lab, a podcast sponsored by AbbVie, with a look at how the company is empowering scientists to boldly rethink what it means to cure disease and accelerate care for patients. Not intended for UK audiences.


To learn more about AbbVie’s approach to scientific discovery, visit: https://www.abbvie.com/science/our-people/community-of-science.html

]]> false full 1 1 <![CDATA[Introducing The People and Stories Driving Health Care Innovation]]> The Persistence Lab, a podcast from AbbVie, invites you to step into the lives of the people who wake up every day determined to solve some of the toughest challenges in medicine and health care. Here, breakthroughs aren’t single moments – they’re the result of questions pursued, experiments refined, and teams who push forward even when the path gets complicated. This is where science meets humanity, and where persistence turns possibilities into real impact for patients. Not intended for UK audiences. 

]]> Tue, 20 Jan 2026 09:21:00 -0500 https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html 2:19 The Persistence Lab, a podcast from AbbVie, invites you to step into the lives of the people who wake up every day determined to solve some of the toughest challenges in medicine and health care. Here, breakthroughs aren’t single moments – they’re the result of questions pursued, experiments refined, and teams who push forward even when the path gets complicated. This is where science meets humanity, and where persistence turns possibilities into real impact for patients. Not intended for UK audiences. 

]]> The Persistence Lab, a podcast from AbbVie, invites you to step into the lives of the people who wake up every day determined to solve some of the toughest challenges in medicine and health care. Here, breakthroughs aren’t single moments – they’re the result of questions pursued, experiments refined, and teams who push forward even when the path gets complicated. This is where science meets humanity, and where persistence turns possibilities into real impact for patients. Not intended for UK audiences. 

]]> false trailer 1